Search - tctmd.com

Displaying 481 - 500 of 814

Sort: Relevancy | Date

Presentation TCT 2016

Percutaneous Coronary Intervention with the ANgiolite Drug-Eluting Stent: an Optical CoHerence TOmogRaphy Study. The ANCHOR Study

Presenter: Fernando Alfonso, Ran Kornowski, Josep Rodés-Cabau

November 01, 2016

Presentation TCT 2016

OCT-guided vs Angio-guided Left Main Treatment: Rationale and Design of the OCTOBER Trial

Presenter: Evald H. Christiansen, Per Hostrup Nielsen, Niels R. Holm

October 31, 2016

News Conference News TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

Complications of Coronary and Peripheral Vascular Intervention

Presenter: Sahil A. Parikh, Ehrin J. Armstrong

October 31, 2016

News Industry News

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

October 31, 2016

Presentation TCT 2016

TCT 4: The Impact of Residual Syntax Score in Octogenarian ACS Patients

Presenter: Andreas Baumbach, Kurt Huber, Seiichi Hiramori

October 31, 2016

Presentation TCT 2016

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Bo Xu

October 31, 2016

Presentation TCT 2016

TCT 31: Impact of Strut Thickness on Short-term Healing Response After Bioresorbable Scaffold Implantation: Serial OCT Evaluation of Novel Thin Strut Sirolimus-Eluting BRS vs Thick Strut Everolimus-Eluting BRS in Porcine Coronary Arteries

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Pawel Gasior

October 31, 2016

Presentation TCT 2016

FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Antonio Colombo

October 31, 2016

Presentation TCT 2016

MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Ashok Seth

October 31, 2016

Presentation TCT 2016

FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Alexandre Abizaid

October 31, 2016

News Industry News

First-In-Human Of New Polymer-Free Stent Demonstrates Favorable Angiographic And Imaging-Based Outcomes At Nine-Months

October 31, 2016

Presentation TCT 2016

REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Stephen G. Worthley

October 31, 2016

News Conference News TCT 2016

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Todd Neale

October 31, 2016

News Industry News

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

October 31, 2016

Presentation TCT 2016

NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Presenter: Martin B. Leon, Keith G. Oldroyd, Evald H. Christiansen

October 31, 2016

Presentation TCT 2016

EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Presenter: Martin B. Leon, Keith G. Oldroyd, Gregg W. Stone

October 31, 2016

Presentation TCT 2016

Canada Presents: Role of IVUS, OCT and FFR in the Assessment of LM Stenosis, and PCI Guidance

Presenter: Thomas Engstroem, Hyo-Soo Kim, Samer Mansour, Quang Ngoc Nguyen, Jean-Michel Paradis

October 30, 2016

Presentation TCT 2016

Is the OCT-derived Healing Score A Meaningful Metric to Evaluate Stent Safety?

Presenter: Fernando Alfonso, Stephan Windecker, Giulio Guagliumi

October 30, 2016

Presentation TCT 2016

OCT-assessed Rate of Early Strut Coverage: Differences Between DES and Its Implications

Presenter: Fernando Alfonso, Stephan Windecker, Stephen WL Lee

October 30, 2016

Advertisement

Percutaneous Coronary Intervention with the ANgiolite Drug-Eluting Stent: an Optical CoHerence TOmogRaphy Study. The ANCHOR Study

OCT-guided vs Angio-guided Left Main Treatment: Rationale and Design of the OCTOBER Trial

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Complications of Coronary and Peripheral Vascular Intervention

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

TCT 4: The Impact of Residual Syntax Score in Octogenarian ACS Patients

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

TCT 31: Impact of Strut Thickness on Short-term Healing Response After Bioresorbable Scaffold Implantation: Serial OCT Evaluation of Novel Thin Strut Sirolimus-Eluting BRS vs Thick Strut Everolimus-Eluting BRS in Porcine Coronary Arteries

FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

First-In-Human Of New Polymer-Free Stent Demonstrates Favorable Angiographic And Imaging-Based Outcomes At Nine-Months

REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Canada Presents: Role of IVUS, OCT and FFR in the Assessment of LM Stenosis, and PCI Guidance

Is the OCT-derived Healing Score A Meaningful Metric to Evaluate Stent Safety?

OCT-assessed Rate of Early Strut Coverage: Differences Between DES and Its Implications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content